(ABOS) Acumen Pharmaceuticals - Performance -72.6% in 12m
Compare ABOS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-78.39%
#134 in Group
Rel. Strength
5.78%
#7497 in Universe
Total Return 12m
-72.55%
#141 in Group
Total Return 5y
-95.12%
#140 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
27th Percentile in Group
12m Total Return: ABOS (-72.6%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ABOS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ABOS
| Total Return (including Dividends) | ABOS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -7.54% | 2.02% | 2.87% |
| 3 Months | -29.49% | -15.44% | -6.42% |
| 12 Months | -72.55% | -14.02% | 9.87% |
| 5 Years | -95.12% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | ABOS | XBI | S&P 500 |
| 1 Month | -18.3% | 57% | 89.4% |
| 3 Months | -87.9% | -82.3% | -72% |
| 12 Months | -87.2% | -53.1% | 49.3% |
| 5 Years | -84.1% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #122 | -9.37% | -10.1% |
| 3 Month | #133 | -16.6% | -24.7% |
| 12 Month | #141 | -68.1% | -75.0% |
| 5 Years | #126 | -91.2% | -96.5% |
FAQs
Does ABOS Acumen Pharmaceuticals outperforms the market?
No,
over the last 12 months ABOS made -72.55%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months ABOS made -29.49%, while XBI made -15.44%.
Over the last 3 months ABOS made -29.49%, while XBI made -15.44%.
Performance Comparison ABOS vs Indeces and Sectors
ABOS vs. Indices ABOS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -8.82% | -10.4% | -64.4% | -82.4% |
| US NASDAQ 100 | QQQ | -9.07% | -12.3% | -64.8% | -83.9% |
| US Dow Jones Industrial 30 | DIA | -9.10% | -9.15% | -63.4% | -78.9% |
| German DAX 40 | DAX | -10.9% | -26.8% | -90.0% | -97.6% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -9.48% | -13.8% | -63.6% | -78.2% |
| Hongkong Hang Seng | HSI | -12.3% | -23.8% | -73.9% | -84.6% |
| India NIFTY 50 | INDA | -6.43% | -9.82% | -66.3% | -74.9% |
| Brasil Bovespa | EWZ | -10.9% | -19.1% | -73.6% | -66.1% |
ABOS vs. Sectors ABOS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9.0% | -11.2% | -70.6% | -92.9% |
| Consumer Discretionary | XLY | -9.74% | -11.1% | -62.2% | -86.6% |
| Consumer Staples | XLP | -8.45% | -9.56% | -71.3% | -80.1% |
| Energy | XLE | -9.80% | -7.62% | -58.4% | -62.8% |
| Financial | XLF | -9.45% | -13.1% | -70.3% | -94.1% |
| Health Care | XLV | -5.03% | -3.16% | -59.2% | -66.6% |
| Industrial | XLI | -10.4% | -14.9% | -65.4% | -82.5% |
| Materials | XLB | -8.81% | -12.3% | -60.4% | -66.5% |
| Real Estate | XLRE | -8.49% | -13.7% | -66.8% | -86.0% |
| Technology | XLK | -9.71% | -14.3% | -62.1% | -79.6% |
| Utilities | XLU | -9.86% | -13.2% | -72.2% | -88.5% |
| Aerospace & Defense | XAR | -9.33% | -16.9% | -73.7% | -97.7% |
| Biotech | XBI | -0.74% | -9.56% | -43.4% | -58.5% |
| Homebuilder | XHB | -8.38% | -10.6% | -50.8% | -62.8% |
| Retail | XRT | -8.97% | -11.1% | -58.1% | -68.2% |